However, the mRNA expression of GFRA3 did not differ significantly between the control and IL-1β-treated cells (IL-1β: 0.1, 1.0, and 10 ng/mL) for both the AF and NP cells (Figure 2e). This evidence concerns the gene IL1B and atrial fibrillation.